Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
Aylin Alkan et al.
BIOMARKER RESEARCH (2021)
Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway
Chen Cai et al.
CANCER SCIENCE (2020)
R2TP/PAQosome as a promising chemotherapeutic target in cancer
Yoshito Kakihara et al.
JAPANESE DENTAL SCIENCE REVIEW (2020)
The role of anthrax toxin protein receptor 1 as a new mechanosensor molecule and its mechanotransduction in BMSCs under hydrostatic pressure
Baixiang Cheng et al.
SCIENTIFIC REPORTS (2019)
PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer
Takeshi Hisamatsu et al.
MOLECULAR CANCER THERAPEUTICS (2019)
PSMD5 Inactivation Promotes 26S Proteasome Assembly during Colorectal Tumor Progression
Avi Levin et al.
CANCER RESEARCH (2018)
GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer Cells
Jinshuai Shan et al.
TRANSLATIONAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability
Adem Bokhari et al.
ONCOGENESIS (2018)
KSR as a therapeutic target for Ras-dependent cancers
Beth K. Neilsen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma
Yung-Kuan Tsou et al.
ONCOTARGET (2017)
Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer
Humair S. Quadri et al.
BMC CANCER (2017)
Spectrum of Gene Mutations in Colorectal Cancer Implications for Treatment
Rodrigo Dienstmann et al.
CANCER JOURNAL (2016)
The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue
Shogo Wada et al.
GENES & DEVELOPMENT (2016)
Mutations and expression of the NFE2L2/KEAP1/CUL3 pathway in Chinese patients with lung squamous cell carcinoma
Yongxing Zhang et al.
JOURNAL OF THORACIC DISEASE (2016)
Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic implications
Hsin-Yi Chen et al.
FRONTIERS IN ONCOLOGY (2016)
SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
Yahui Du et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer
Fabio Coppede et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Dual Mechanism of Interleukin-3 Receptor Blockade by an Anti-Cancer Antibody
Sophie E. Broughton et al.
CELL REPORTS (2014)
PIH1D1 interacts with mTOR complex 1 and enhances ribosome RNA transcription
Yuya Kamano et al.
FEBS LETTERS (2013)
Specific expression of k63-linked ubiquitination of calmodulin-like protein 5 in breast cancer of premenopausal patients
Manuel Debald et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer
S. T. Martin et al.
BRITISH JOURNAL OF SURGERY (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Molecular Genetics of Colorectal Cancer
Eric R. Fearon
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Frameshift mutation hotspot identified in Smith-Magenis syndrome: case report and review of literature
Hoa T. Truong et al.
BMC MEDICAL GENETICS (2010)
Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer
Michael S. Nahorski et al.
JOURNAL OF MEDICAL GENETICS (2010)
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling
Seung-Beom Hong et al.
MOLECULAR CANCER (2010)
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer:: Primary or secondary genetic events in colorectal carcinogenesis?
Sergia Velho et al.
BMC CANCER (2008)
Colorectal cancer: genetics of development and metastasis
T Takayama et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Genetic predisposition to colorectal cancer
A de la Chapelle
NATURE REVIEWS CANCER (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Response to preoperative chemoradiation in Stage II and III rectal cancer
CL Brown et al.
DISEASES OF THE COLON & RECTUM (2003)
The colorectal adenoma-carcinoma sequence
A Leslie et al.
BRITISH JOURNAL OF SURGERY (2002)
The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
DC Chung
GASTROENTEROLOGY (2000)
Share Paper
